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ORIGINAL ARTICLE
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Abstract
Considerable evidence suggests that adolescent exposure to delta-9-tetrahydrocanabinol (THC), the psychoactive component in
marijuana, increases the risk of developing schizophrenia-related symptoms in early adulthood. In the present study, we used a
combination of behavioral and molecular analyses with in vivo neuronal electrophysiology to compare the long-term effects of
adolescent versus adulthood THC exposure in rats. We report that adolescent, but not adult, THC exposure induces long-term
neuropsychiatric-like phenotypes similar to those observed in clinical populations. Thus, adolescent THC exposure induced
behavioral abnormalities resembling positive and negative schizophrenia-related endophenotypes and a state of neuronal
hyperactivity in the mesocorticolimbic dopamine (DA) pathway. Furthermore, we observed profound alterations in several
prefrontal cortical molecular pathways consistent with sub-cortical DAergic dysregulation. Our ﬁndings demonstrate a
profound dissociation in relative risk proﬁles for adolescent versus adulthood exposure to THC in terms of neuronal, behavioral,
and molecular markers resembling neuropsychiatric pathology.
Key words: adolescence, cannabis, dopamine, prefrontal cortex, ventral tegmental area

Introduction
Marijuana (MJ) is the most commonly used illicit drug by adolescents. Indeed, chronic MJ use among teens is occurring at earlier
ages and with increasing global prevalence (Substance Abuse and
Mental Health Services Administration 2013). Importantly, adolescence represents a critical neurodevelopmental period characterized by increased neural plasticity and vulnerability to
extrinsic insult, particularly in cortical and limbic regions
(Spear 2000). This maturational period also involves extensive reorganization of various neurotransmitter systems such as the
glutamatergic, GABAergic, dopaminergic, and endocannabinoid
systems (Spear 2000). Although it is still a matter of debate,
there is evidence suggesting that chronic adolescent MJ exposure

may be associated with a higher risk for neuropsychiatric
diseases, including schizophrenia (Andréasson et al. 1987;
Arseneault et al. 2002, 2004; Stefanis et al. 2004; Renard et al.
2014). Δ-9-Tetrahydrocannabinol (THC), the psychoactive component of MJ, acts as a partial agonist of CB1 cannabinoid receptors
(CB1Rs), one of the most abundantly expressed G protein-coupled
receptors (GPCRs) in the central nervous system (CNS) (Herkenham et al. 1990). CB1Rs are key players in the control and maintenance of synaptic plasticity (Kano et al. 2009) and are thought
to be central components of the neurodevelopmental changes
occurring during adolescence (Ellgren et al. 2008). Increasing evidence points to the clinical risks associated with exposure to
popular street strains of cannabis containing higher and higher
relative THC content. For example, the popularity of cannabis
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strains such as sinsemilla, which contain high levels of THC, has
been linked to an increased risk of developing ﬁrst-episode
psychotic symptomology (Di Forti et al. 2009). Nevertheless, the
precise neuronal and molecular mechanisms by which adolescent THC exposure may lead to schizophrenia-related symptoms
are not well understood.
Schizophrenia represents a complex disorder associated with
various disturbances in motivational, social, emotional, and cognitive processing that is linked to profound disturbances in
mesocorticolimbic dopamine (DA) transmission. By regulating
excitatory and inhibitory inputs controlling mesocorticolimbic
DA neurons, CB1Rs modulate DAergic activity (French et al.
1997; Melis et al. 2004) in neural regions such as the ventral tegmental area (VTA) and prefrontal cortex (PFC) (Laviolette 2007),
both of which contain high levels of CB1Rs (Kano et al. 2009)
and which are functionally connected via ascending and descending neural pathways (Laviolette 2007). Importantly, considerable evidence demonstrates that chronic cannabis exposure
can alter mesocorticolimbic DAergic signaling (Bloomﬁeld et al.
2014). However, the precise mechanisms by which chronic adolescent THC exposure may disturb neuronal and molecular pathways within the mesocorticolimbic circuitry and thereby disrupt
normal DAergic function are currently unknown.
At the molecular level, considerable evidence implicates the
interconnected wingless (Wnt) signaling cascade (i.e., protein
kinase B [Akt], glycogen synthase kinase-3 [GSK-3], β-Catenin)
and the mammalian target of rapamycin (mTOR) (i.e., p70S6
Kinase [ p70S6K]) signal transduction pathways as crucial molecular substrates underlying schizophrenia-related psychopathology and antipsychotic efﬁcacy (Alimohamad et al. 2005; Valjent
et al. 2011; Sutton and Rushlow 2012; Gururajan and Van Den
Buuse 2014). For example, haloperidol, clozapine, and risperidone alter GSK-3 and β-catenin protein expression levels in the
PFC and striatum of rats (Alimohamad et al. 2005). In addition,
haloperidol increases phosphorylation level of p70S6K in D2Rexpressing striatal neurons (Valjent et al. 2011). Importantly,
CB1R activation can modulate these downstream signaling pathways in various neural regions (Ozaita et al. 2007; Puighermanal
et al. 2009), raising the possibility that THC-induced dysregulation in these pathways may underlie schizophrenia-related
psychopathology.
In the present study, we used a combination of behavioral assays, molecular analyses, and in vivo neuronal electrophysiology
to model endophenotypes similar to those observed in schizophrenia and other neuropsychiatric disorders. We report that
THC exposure during adolescence leads to an array of persistent
cognitive and behavioral disturbances and enduring molecular
abnormalities in the PFC bearing remarkable similarity to adaptations observed in neuropsychiatric populations, including
changes in the Akt, Wnt, and mTOR pathways. Finally, we report
for the ﬁrst time that adolescent THC exposure induces a persistent state of hyper-DAergic activity in the VTA and associated
molecular adaptations in the PFC.

Materials and Methods
Animals
Adolescent and adult male Sprague-Dawley rats were obtained at
postnatal day (PND) 30 and 60, respectively, from Charles River
Laboratories (Quebec, Canada). At arrival, rats were pair-housed
under controlled conditions (12 h light/dark cycle, constant temperature, and humidity) with free access to food and water. All
procedures were performed in accordance with Governmental

and Institutional guidelines for appropriate animal care and
experimentation.

Drug Preparation and Administration
Rats treated with THC (Tocris, UK) received twice daily injections
of THC (2.5 mg/kg; Days 1–3; 5 mg/kg; Days 4–7; 10 mg/kg, Days 8–11).
Control groups received the same injection schedule (volume adjusted per body weight) with vehicle (VEH). Increasing doses of
THC were administered to counter the development of drug tolerance (González et al. 2005). This THC dosing regimen was chosen
based on previous studies (Rubino et al. 2009) and is known to produce long-term behavioral impairments in rats. THC was dissolved
in ethanol, cremophor, and saline (1:1:18). Ethanol was then evaporated using nitrogen gas to remove it from the ﬁnal THC solution. All
injections were administered intraperitoneally (i.p) at a volume of
1 mL/kg. The adolescent and adult THC exposure experiments
began at PND 35 and 65, respectively. Behavioral tests were initiated
following a 30-day drug-free period (at PND 75 for the adolescent
group and PND 105 for the adult group).

Social Motivation and Social Cognition Testing
Rats were tested using a social interaction procedure as described
previously (Loureiro et al. 2014). Brieﬂy, this task evaluates 2 distinguishable aspects of social behavior: 1) social afﬁliation/
motivation and 2) social recognition memory. Rats were habituated to the test arena for 13 min, 24 h before testing. Testing consisted of 2 successive 8-min phases. During the ﬁrst phase, we
analyzed social motivation, that is, the propensity to spend
time with an unfamiliar male rat (stranger rat) enclosed in a
small wire cage compared with time spent with an identical
but empty cage. Thus, the test rat had a choice between the stranger rat and an empty cage. During the second phase, occurring
just after the ﬁrst one, we analyzed social recognition, that is,
the propensity to spend time with a novel unfamiliar rat (novel
stranger) rather than with the familiar stranger rat ( previously
encountered). The novel stranger was placed in the chamber
that had been empty during the ﬁrst 8-min session. Therefore,
the tested rat had a choice between the ﬁrst, already investigated
familiar stranger and the novel stranger. In this situation, control
rats will spend signiﬁcantly more time with the novel stranger,
demonstrating a natural preference for social novelty. The locations of stranger versus novel rats in the left versus right side
chambers were counterbalanced between trials. Times spent in
exploration were videotaped with a video-tracking system
(ANY-maze; Stoelting) and analyzed by an experimenter blind
to the treatment conditions.
After each rat testing, chambers and cages were cleaned with
50% ethanol to avoid olfactory cue bias. Two rats (1 adolescent
VEH pre-treated rat and 1 adult THC pre-treated rat) were
excluded from the experiment due to a lack of spontaneous
exploratory behavior (deﬁned as an exploration time <10 s during
both phases of the test).

Light–Dark Box Test
This test is based upon a rat’s natural aversion to bright environments and attributes greater time spent in an illuminated environment as reﬂecting lower anxiety levels. The test apparatus
consisted of two 50 × 25 × 37 cm compartments. Between the
compartments was a 10 × 10 cm door allowing the rat to enter
either side. One compartment was black and covered with a
black lid (the dark box), while the other compartment was
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white, left uncovered, and brightly illuminated by a lamp located
120 cm above the apparatus ﬂoor, providing 1500 lux at ﬂoor level
(the light box). At the start of the experiment, a rat was placed in
the center of the lighted box with its head facing the wall opposite
the door and was allowed to freely explore both compartments for a
period of 8 min. A zone entry was considered to have begun when
the animal placed all 4 paws in that zone. Experiments were videotaped with a video-tracking system (ANY-maze; Stoelting) and analyzed by an experimenter blind to treatment conditions. Behaviors
analyzed included: 1) latency time to ﬁrst entry in the dark box; 2)
latency time for re-entering the light box, and 3) total number of
transitions between compartments. The latency to leave the dark
box and enter the light box is thought to be the most reliable indicator of anxiety-like behavior and is sensitive to both anxiogenic and
anxiolytic treatments (Ardayﬁo and Kim 2006).

Prepulse Inhibition of Startle Reﬂex
Rats were acclimatized to the startle chambers (Med Associates,
USA) for 5 min over 3 days. On the last day of acclimatization, rats
were tested in an input/output (I/O) function consisting of 12 increasing startle pulses (from 65 to 120 dB, 5 dB increments) to determine the appropriate gain setting for each individual rat. The
testing paradigm consisted of the following phases: the acclimatization phase, a habituation phase (Block 1), and PPI measurement (Block 2). During acclimatization, rats were exposed to the
chambers and white background noise (68 dB) for 5 min. During
Block 1, 10 pulse alone trials (110 dB white noise, 20 ms duration)
were delivered at 15–20 s intervals. Block 2 consisted of the presentation of 9 different trials presented 10 times, each in a pseudorandomized order, and at 30 s intervals: 10 pulse-alone trials
and 10 of each of 3 different prepulse–pulse trial types (72, 76, 80)
with interstimulus intervals (ISI) of 100 ms. “Pulse-alone” trials consisted of a startle stimulus-only presentation, while “prepulse–
pulse” trials consisted of the presentation of a weaker nonstartling
prepulse (white noise, 20 ms duration, volume as indicated) before
the startling stimulus. PPI was calculated for each animal and each
trial condition as PPI (%) = (1 − average startle amplitude to pulse
with prepulse/average startle amplitude to pulse only) × 100.

Open Field Test
Rats were placed in an automated open ﬁeld activity chamber (Med
Associates, San Diego, CA, USA). Total distance travelled and total
stereotypy and vertical counts were recorded for 60 min.

In Vivo VTA Electrophysiological Recordings
Single-unit extracellular VTA recordings were performed on rats
anesthetized with urethane (1.4 g/kg, i.p) and placed in a stereotaxic frame with body temperature maintained at 37°C. A scalp incision was made, and a hole was drilled in the skull overlaying the
VTA. For VTA recordings, glass microelectrodes (with an average
impedance of 6–8 MΩ) ﬁlled with a 2% pontamine sky blue solution were lowered using a hydraulic micro-positioner (Kopf640)
at the following coordinates: AP: −5.2 mm from bregma, L:±0.8–
1 mm, DV: −6.5 to −9 mm from the dural surface. Extracellular signals were ampliﬁed using a MultiClamp700B ampliﬁer (Molecular
Devices) and recorded through a Digidata1440A acquisition system (Molecular Devices) using pClamp10 software. Recordings
were ﬁltered at 1 kHz and sampled at 5 kHz. Presumptive VTA
DA neurons were identiﬁed according to the following well-established electrophysiological features (Ungless and Grace 2012): 1)
action potential (AP) with biphasic or triphasic waveform with
duration >1.1 ms from the start of the action potential to the
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negative trough; 2) a slow spontaneous ﬁring rate (∼2–5 Hz), and
3) a single irregular or bursting ﬁring pattern. Electrophysiological
analyses were performed ofﬂine using the Clampﬁt10 (Molecular
Devices) software package. The electrophysiological properties of
spontaneously active DA neurons were sampled in the VTA by
making 6 vertical passes of the electrode through the DA cell
body region. These tracks were made in a predeﬁned pattern,
with each track separated by 200 µm. After an individual DA neuron was isolated, its spontaneous activity was recorded for 5 min.
Two parameters of activity were sampled, the basal ﬁring rate and
the proportion of spikes ﬁred by the DA neurons that occurred in
bursts. The onset of a burst was deﬁned as the occurrence of 2
spikes with an interspike interval of 80 ms (Grace and Bunney
1983). The percentage of spikes in bursts was calculated by dividing the number of spikes occurring in bursts by the total number of
spikes occurring in the same period of time. The basal ﬁring rates
of all DA neurons and the % of spikes in bursts were calculated as
an average value for each rat and analyzed using 2-tailed t-tests.
For histological analysis, recording electrode locations were marked
with iontophoretic deposit of pontamine sky blue (−20 μA for
15 min). Brains were removed and rapidly frozen. Brains were
cut using a brain block to obtain blocks of tissue containing the
VTA or PFC. The VTA block was cut using a cryostat to obtain sections (60 μm) that were stained with neutral red to conﬁrm the
neuronal recording site. Cells recorded outside the anatomical
boundaries of the VTA were excluded from data analysis.

Protein Extraction and Western Blotting
The block containing the PFC was cut using a cryostat to obtain
coronal sections (60 μm) from which bilateral micropunches of
the PFC were obtained for protein isolation. The western blotting
procedure was performed as described previously (Lyons et al.
2013). Primary antibody dilutions were as follows: α-tubulin
(1:120 000; Sigma-Aldrich), phosphorylated GSK-3α/β ser21/9
( p-GSK-3α/β; 1:1000; Cell Signaling Technology), total GSK-3α/β
ser21/9 (t-GSK-3α/β; 1:1000; Cell Signaling Technology), phosphorylated Akt Ser473 ( p-Akt-Ser473; 1:1000; Cell Signaling Technology), phosphorylated Akt thr308 ( p-Akt-thr308; 1:1000; Cell
Signaling Technology), total Akt (t-Akt; 1:1000; Cell Signaling
Technology), β-catenin (1:10 000; Sigma-Aldrich), phosphorylated
mTOR ser2448 ( p-mTOR;1:2000; Cell Signaling Technology), total
mTOR (t-mTOR; 1:2000, Cell Signaling Technology), phosphorylated p70S6K thr389 ( p-p70S6K; 1:1000; Cell Signaling Technology), total p70S6K (t-p70S6K; 1:1000; Cell Signaling Technology).
Species appropriate horseradish peroxidase (HRP)-conjugated
secondary antibodies (Thermo Scientiﬁc) were all used at a
dilution of 1:20 000.

Statistical Analyses
Data were analyzed with 2-tailed t-tests or 2-way repeated-measures ANOVA where appropriate. Post hoc analyses were performed with Fisher’s LSD. Values and SEMs for each behavioral
test are presented in Supplementary Table 1. Densitometry values for western blots were obtained with Kodak digital analysis
software and analyzed with t-tests.

Results
THC Exposure During Adolescence Versus Adulthood
Differentially Modulates Social Interaction and Cognition
Disturbances in social interaction and cognition are commonly
observed in schizophrenia (Marwick and Hall 2008). Accordingly,
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we evaluated the long-term effects of adolescent versus adulthood THC exposure on social motivation/cognition (Fig. 1A). In
adolescent THC rats, analysis of interaction times with a novel
stranger revealed that THC rats spent signiﬁcantly less time
than VEH rats exploring the stranger rat (t (15) = −3.022; P < 0.01;
Fig. 1B). During the social recognition test, 2-way repeated-measures ANOVA comparing times spent with novel versus familiar
rats showed a signiﬁcant effect of novelty (F1,33 = 9.734; P < 0.01).
Post hoc analysis revealed that while VEH-treated rats displayed
a clear preference for novel versus familiar rats (P < 0.05;
Fig. 1C), THC rats showed no preference (P > 0.05; Fig. 1C).
In contrast, in adult treated rats, analysis of times spent with the
stranger rat during the social motivation test, showed that both VEH
and THC rats spent the same length of time exploring the stranger
rat (t(16) = −0.054; P > 0.05; Fig. 1D). During the social recognition test,

2-way repeated-measures ANOVA comparing times spent with
novel versus familiar rats showed a signiﬁcant effect of novelty
(F1,35 = 6.83; P < 0.05). Post hoc analysis revealed that while VEH rats
displayed a signiﬁcant preference for novel versus familiar rats (P <
0.05; Fig. 1E), THC rats spent the same length of time exploring novel
versus familiar rats (P > 0.05; Fig. 1E). Thus, THC exposure during
adolescence but not adulthood induced long-term deﬁcits in social
motivation. However, both adolescent and adulthood THC exposure induced deﬁcits in social cognition/memory.

Adolescent THC Exposure Induces Long-Term Deﬁcits in
Exploratory Behaviors
We next evaluated the long-term effects of adolescent versus
adult THC exposure on exploratory behaviors in a novel

Figure 1. Long-term effects of chronic THC exposure during either adolescence or adulthood on social motivation and social recognition. (A) Apparatus and rats’
placements for the social motivation and social recognition test, respectively. (B) During the social motivation test, adolescent THC pretreated rats spent signiﬁcant
less time than VEH rats exploring the stranger rat. (C) During the social recognition test, adolescent VEH pretreated rats displayed a clear preference for the novel rat
in comparison with the familiar one, whereas adolescent THC pretreated rats spent the same length of time exploring both the novel and the familiar rats. (D) During
the social motivation test, both adult VEH and THC pretreated rats spent the same amount of time exploring the stranger rat. (E) During the social recognition test,
adult VEH pretreated rats displayed a clear preference for the novel rat in comparison with the familiar one, whereas adult THC pretreated rats spent the same length
of time exploring both the novel and the familiar rats. Adolescent pretreated rats: n = 8 VEH and n = 9 THC; Adult pretreated rats: n = 10 VEH and n = 8 THC. Two-tailed
t-tests or two-way repeated-measures ANOVA; ** indicated P < 0.01; * indicated P < 0.05. Error bars represent the standard error of the means (SEMs).
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environment (i.e., the open ﬁeld test). Statistical analysis revealed that adolescent THC rats travelled less distance relative
to VEH controls (t (16) = −2.393; P < 0.05; Fig. 2A). Examples of typical activity plots for adolescent VEH or THC-treated rats are presented in Figure 2B. In addition, adolescent THC rats displayed
less rearing relative to VEH controls (t (16) = −2.861; P < 0.05;
Fig. 2C). In contrast, in adult pretreated rats, analysis of locomotor
activity and rearing counts revealed no signiﬁcant differences between VEH- versus THC-treated rats (t (19) = −1.812; P > 0.05 and
t (19) = 0.092; P > 0.05, Fig. 2D,E, respectively).

THC Exposure During Adolescence Induces Long-Term
Increases in Anxiety Measures
We next compared the effects of adolescent versus adult THC
exposure on anxiety levels using the light–dark box test (Fig. 3A).
In adolescent THC rats, statistical analysis comparing latency to
ﬁrst entry in the dark box revealed that both adolescent THC
and VEH rats displayed similar entry latency times (t (18) = −1.461;
P > 0.05; Fig. 3B). However, THC rats exhibited a signiﬁcantly longer
latency to emerge from the dark to the light box relative to VEH controls (t(18) = −2.374; P < 0.05; Fig. 3C). In addition, THC rats performed
less total transitions between compartments compared with VEH
control (t(18) = 3.432; P < 0.01; Fig. 3D). In adult treated rats, statistical
analysis revealed that both VEH and THC rats spent similar
amounts of time 1) entering the dark box (t (19) = 0.432; P > 0.05;
Fig. 3E) and 2) re-entering the light box (t (19) = 0.219; P > 0.05;
Fig. 3F). VEH and THC rats also displayed similar numbers of transitions between compartments (t(19) = 0.124; P > 0.05; Fig. 3G). Thus,
adolescent, but not adulthood THC exposure, induces long-lasting
effects on anxiety levels.
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Adolescent THC Exposure Induces Long-Term Deﬁcits in
Sensorimotor Gating
Deﬁcits in sensorimotor gating are a well-established endophenotype of schizophrenia (Braff and Geyer 1990). Accordingly, we next
compared the effects of adolescent versus adult THC exposure on
sensorimotor gating using the PPI procedure (see methods; Fig.4).
In adolescent treated rats, 2-way repeated-measures ANOVA on
PPI responses revealed a nearly signiﬁcant effect of treatment
(F1,50 = 4.23; P = 0.057) and a signiﬁcant effect of prepulse intensity
factor (F2,50 = 7.25; P < 0.01). Post hoc comparisons revealed that THC
rats displayed PPI deﬁcits at prepulse intensity levels of 76 dB (P <
0.05) and 80 dB (P < 0.01) compared with VEH controls (Fig. 4A).
The startle amplitude responses were unchanged between groups
(t(15) = 0.423; P > 0.05; Fig. 4B). In adult treated rats, 2-way repeatedmeasures ANOVA on PPI responses showed a signiﬁcant effect of
prepulse intensity factor (F2,62 = 5.02; P < 0.05). Post hoc comparisons
revealed that there were no signiﬁcant differences between THC
and VEH groups at the different prepulse intensities tested ( ps >
0.05; Fig. 4C). Startle amplitude responses were unchanged between groups (t (19) = −0.122; P > 0.05; Fig. 4D). These data demonstrate that THC exposure during adolescence, but not adulthood,
induces lasting deﬁcits in sensorimotor gating. Importantly the
long-term PPI deﬁcits observed in adolescent pre-treated rats are
not confounded with reduced startle amplitudes, since no changes
were observed between THC and VEH rats on this variable.

Adolescent THC Exposure Induces a Sub-Cortical
Hyper-DAergic State
We next evaluated the long-term effects of adolescent versus
adulthood THC exposure on spontaneous VTA DA neuronal

Figure 2. Long-term effects of chronic THC exposure during either adolescence or adulthood on exploratory/motivation behavior. (A) Adolescent THC pretreated rats
travelled less distance relative to VEH controls. (B) Examples of typical activity plots for adolescent VEH (top) or THC (bottom) treated rats. (C) Adolescent THC
pretreated rats did less rearing counts relative to VEH controls. (D) Adult VEH and THC pretreated rats travelled the same distance and (E) did the same number of
rearing. Adolescent pretreated rats: n = 9 VEH and n = 9 THC; Adult pretreated rats: n = 11 VEH and n = 10 THC. Two-tailed t-tests; ** indicated P < 0.01; * indicated
P < 0.05. Error bars represent the standard error of the means (SEMs).
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Figure 3. Long-term effects of chronic THC exposure during either adolescence or adulthood on anxiety level. (A) Apparatus and rats’ placements for the anxiety test. (B) In
adolescent pretreated rats, both THC and VEH rats spent the same amount of time for entering the dark box. (C) Adolescent THC pretreated rats exhibited a longer latency
to emerge from the dark to the light box compared with VEH controls. (D) Adolescent THC pretreated rats did less total transitions between compartments compared with
VEH controls. (E) In adult pretreated rats, both VEH and THC rats spent the same amount of time for entering the dark box and (F) re-entering the light box. (G) Adult VEH
and THC pretreated rats did the same number of transitions between compartments. Adolescent pretreated rats: n = 9 VEH and n = 11 THC; Adult pretreated rats: n = 11 VEH
and n = 10 THC. Two-tailed t-tests; ** indicated P < 0.01; * indicated P < 0.05. Error bars represent the standard error of the means (SEMs).

activity parameters. A microphotograph of a representative VTA
neuronal recording placement is shown in Figure 5A. In adolescent treated rats, statistical analysis revealed that THC-exposed
rats displayed signiﬁcantly increased VTA DA neuronal ﬁring
frequencies (t (12) = −3.733; P < 0.01; Fig. 5B) and a signiﬁcantly
increased relative proportion of spikes ﬁring in burst mode
(t (12) = −2.702; P < 0.05; Fig. 5C) relative to VEH controls. Representative rastergrams showing spontaneous activity of typical VTA
DA neurons in THC versus VEH pretreated rats are presented in

Figure 5D. Sample VTA DA neuronal recording traces from THC
versus VEH pretreated rats are presented in Figure 5E.
In contrast, in adult THC-treated rats, analysis of VTA DA
neuronal ﬁring frequency and spikes ﬁring in burst mode
revealed no signiﬁcant effects of treatment (t (11) = 0.238; P > 0.05;
and t (11) = 0.737; P > 0.05, Fig. 5F,G respectively). Representative
rastergrams comparing the spontaneous activity of VTA DA
neurons in THC versus VEH pretreated rats are shown in
Figure 5H. Thus, THC exposure during adolescence, but not

Effects of Adolescent Cannabinoid Exposure Renard et al.
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Figure 4. Long-term effects of chronic THC exposure during either adolescence or adulthood on sensorimotor gating. (A) In adolescent pretreated rats, THC rats displayed
PPI deﬁcits at both the prepulse intensity levels of 76 and 80 dB compared with VEH control rats. (B) The startle amplitude responses were unchanged in adolescent VEHversus THC pretreated rats. (C) In adult pretreated rats, there were no PPI deﬁcits in THC versus VEH at the different prepulse intensities tested. (D) The startle amplitude
responses were unchanged in adult VEH- versus THC pretreated rats. Adolescent pretreated rats: n = 8 VEH and n = 9 THC; Adult pretreated rats: n = 11 VEH and n = 10 THC.
Two-way repeated-measures ANOVA; ** indicated P < 0.01; * indicated P < 0.05. Error bars represent the standard error of the means (SEMs).

during adulthood, selectively induces long-term hyper-DAergic
activity in the VTA.

Adolescent THC Exposure Induces Dramatic Decreases in
PFC Phosphorylated Protein Levels of GSK-3α/β, Akt
Thr308, mTOR, p70S6 Kinase, and β-Catenin
We next analyzed PFC protein expression levels of the interconnected Wnt/Akt and mTOR signaling pathways (β-catenin, GSK-3,
Akt, p70S6K, and mTOR), comparing adolescent VEH- versus
THC pretreated rats. Western blot analysis of phosphorylated
Akt-Thr308 ( p-Akt-Thr308) revealed a dramatic decrease in adolescent THC versus VEH-treated rats (Fig. 6A). This decrease was
so profound that quantiﬁcation of protein levels in adolescent
THC-treated samples was not possible within the linear range
of the ﬁlm nor could a band be detected even following over exposure (Fig. 6A). However, the density of protein expression of
total Akt (t-Akt) was unchanged between groups (P > 0.05). We
further found no signiﬁcant difference in levels of phosphorylated Akt-Ser473 ( p-Akt-Ser473), the expression of total Akt protein levels (t-Akt) or the ratio of p-Akt-Ser473/t-Akt between
adolescent VEH- and THC pretreated rats (P > 0.05; Fig. 6B). Analysis of β-catenin protein expression revealed a signiﬁcant decrease between adolescent VEH- versus THC pretreated rats
(t (10) = 1.77; P < 0.05; Fig. 6C). Western blot analyses revealed a

signiﬁcant decrease in levels of both phosphorylated GSK-3
α and β ( p-GSK-3 α ; β) (t (10) = 3.73; P < 0.01 and t (10) = 3.41; P < 0.01;
respectively), the ratio of both p-GSK-3 α /total-GSK-3 α expression (t (10) = 3.56; P < 0.01) and p-GSK-3 β/total-GSK-3 β expression
(t (10) = 2.87; P < 0.05) when comparing adolescent VEH- versus
THC pretreated rats (Fig. 6D). Expression of total GSK-3 β and
GSK-3 α protein levels (t-GSK-3 β and t-GSK-3 α, respectively)
were unaffected (P > 0.05; Fig. 6D). Western blot analyses also revealed a signiﬁcant decrease in levels of phosphorylated mTOR
( p-mTOR) (t (6) = 2.52; P < 0.05) and the ratio of p-mTOR/total
mTOR expression (t (6) = 2.077; P < 0.05) when comparing adolescent VEH- versus THC pretreated rats (Fig. 6E). Expression of
total mTOR protein levels (t-mTOR) was unaffected (t (6) = 0.33;
P > 0.05; Fig. 6E). Finally, Western blot analyses revealed a signiﬁcant decrease in levels of phosphorylated-p70S6K ( p-p70S6K)
(t (6) = 17.68; P < 0.001), total p70S6K protein levels (t-p70S6K)
(t (6) = 11.65; P < 0.001; Fig. 6F), and the ratio of p-p70S6K/totalp70S6K expression (t (6) = 6.92; P < 0.001) when comparing adolescent VEH- versus THC pretreated rats (Fig. 6F).

Adulthood THC Exposure Increases Phosphorylation of
GSK-3α/β, Akt Ser473, and mTOR in the PFC
In contrast to observations in adolescent treated rats, analysis of
PFC protein expression levels in adult treated rats revealed no
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Figure 5. Long-term effects of chronic THC exposure during either adolescence or adulthood on spontaneous VTA-DA neuron activity. (A) Microphotograph of a
representative VTA neuronal recording placement. (B) Adolescent THC pretreated rats displayed increasing spontaneous VTA DA neuronal ﬁring frequency and (C)
increasing spikes ﬁring in burst mode compared with VEH rats. (D) Representative rastergram showing the spontaneous activity of 1 DA neuron in an adolescent THC
(top) or VEH (bottom) pretreated rat. (E) Sample VTA DA neuronal recording traces from THC (top) or VEH (bottom) pretreated rats. (F) In adult pretreated rats, both
VEH and THC pretreated rats displayed similar spontaneous VTA DA neuronal ﬁring frequency and (G) spikes ﬁring in burst mode. (H) Representative rastergram
showing the spontaneous activity of 1 DA neuron in an adult THC (top) or VEH (bottom) pretreated rat. Adolescent pretreated rats: n = 63 cells in 8 VEH rats and n = 62
cells in 6 THC rats; Adult pretreated rats: n = 41 cells in 7 VEH rats and n = 31 cells in 6 THC rats. Two-tailed t-tests; ** indicated P < 0.01; * indicated P < 0.05. Error bars
represent the standard error of the means (SEMs).

signiﬁcant difference in levels of phosphorylated Akt-Thr308
( p-Akt- Thr308), the expression of total Akt protein levels
(t-Akt) and the ratio of p-Akt -Thr308/t-Akt between adult VEHversus THC pre-treated rats (Ps > 0.05; Fig. 7A). In contrast, we
found a signiﬁcant increase in levels of phosphorylated AktSer473 ( p-Akt-Ser473) (t (6) = 2.60; P < 0.05) and the ratio of p-AktSer473/total-Akt (t (6) = 3.88; P < 0.01) when comparing adult

VEH- versus THC pretreated rats (Fig. 7B). Expression of total
Akt protein levels (t-Akt) was unaffected (t (6) = 2.30; P > 0.05;
Fig. 7B). Analysis of β-catenin expression revealed no signiﬁcant changes between adult VEH- versus THC pretreated rats
(t (7) = 0.98; P > 0.05) (Fig. 7C). Western blot analyses revealed a signiﬁcant increase in levels of both phosphorylated GSK-3 α and β
isoforms ( p-GSK-3 α; β) (t (6) = 2.59; P < 0.05 and t (6) = 2.39; P < 0.05;
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Figure 6. Long-term effects of chronic THC exposure during adolescence on PFC synaptic markers. (A) A dramatic decrease in phosphorylated Akt-Thr308 was found in
adolescent THC versus VEH-treated rats. (B) Representative western blot for phosphorylated and total Akt expression in the PFC (left). No signiﬁcant changes were found in
phosphorylated Akt-Ser473, the total Akt and the ratio of phosphorylated to total Akt between adolescent VEH and adolescent THC pretreated rats. (C) Representative
western blot for β-catenin expression in the PFC (left). A signiﬁcant decrease in β-catenin expression is observed between adolescent VEH and adolescent THC
pretreated rats. (D) Representative western blot for phosphorylated and total GSK-3α and β expression in the PFC (left). Densitometry analysis revealed a decrease in
both phosphorylated GSK-3α and β isoforms and both the ratio of phosphorylated to total (GSK-3α and GSK-3β) in adolescent THC compared with adolescent VEH
pretreated rats. No signiﬁcant changes in total GSK-3α and β were found between groups. (E) Representative western blot for phosphorylated and total mTOR
expression in the PFC (left). Densitometry analysis revealed a decrease in both phosphorylated mTOR and the ratio of phosphorylated to total mTOR in adolescent
THC compared with adolescent VEH pretreated rats. No signiﬁcant changes in total mTOR are observed. (F) Representative western blot for phosphorylated and total
p70S6K expression in the PFC (left). Densitometry analysis revealed a decrease in phosphorylated p70S6K, the ratio of phosphorylated to total p70S6K and total
p70S6K in adolescent THC compared with adolescent VEH pretreated rats. n = 4–6 rats, t-tests; ** indicated P < 0.01; * indicated P < 0.05. Error bars represent the
standard error of the means (SEMs).

respectively), the ratio of both p-GSK-3 α /total-GSK-3 α expression (t (6) = 6.15; P < 0.01) and p-GSK-3 β/total- GSK-3 β expression
(t (6) = 3.51; P < 0.01) when comparing adult VEH- versus THC pretreated rats (Fig. 7D). Expression of total GSK-3 β and GSK-3 α protein levels (t-GSK-3 β and t-GSK-3 α, respectively) was unaffected
(Ps > 0.05; Fig. 7D).
Western blot analyses also revealed a signiﬁcant increase in
levels of phosphorylated mTOR ( p-mTOR) (t (6) = 2.92; P < 0.05)
and the ratio of p-mTOR/total mTOR expression (t (6) = 3.67;
P < 0.05) when comparing adult VEH- versus THC pretreated rats
(Fig. 7E). Expression of total mTOR protein levels (t-mTOR) was
unaffected (t (6) = 0.35; P > 0.05; Fig. 7E). Finally, Western blot analyses revealed no signiﬁcant changes in levels of phosphorylated-p70S6K ( p-p70S6K), total p70S6K protein levels (t-p70S6K),
and the ratio of p-p70S6K/total-p70S6K expression (when comparing adult VEH- versus THC pretreated rats [Ps > 0.05; Fig. 7F]).

Discussion
The present study demonstrates that exposure to chronic THC
during a speciﬁc window of adolescent neurodevelopment can
induce enduring neuropsychiatric-like behavioral, molecular,

and neuronal phenotypes, at the cortical and sub-cortical levels.
Importantly, these effects were selectively limited to adolescent
exposure as the majority of observed behavioral and neuronal alterations were not present following adulthood exposure. In addition, several of the observed molecular adaptations within the
PFC occurred in opposite directions following adolescent versus
adult THC exposure.
Behaviorally, rats receiving adolescent THC exposure displayed exploratory deﬁcits in novel environments, which may
be indicative of decreased motivational drive and/or ﬂattened
affect (Katz et al. 1981). In addition, THC treatment induced deficits in normal social interaction behaviors and cognition, which
are well-established markers of prodromal and/or existing neuropsychiatric-related pathology (Marwick and Hall 2008; Green and
Horan 2010). Interestingly, adult THC exposure induced deﬁcits
only in social memory, suggesting that both adolescent and
adulthood exposure to chronic THC can induce social cognition
deﬁcits, consistent with previous reports indicating that chronic
MJ exposure during adulthood may induce memory-related cognitive impairments (O’Shea et al. 2006; Schneider et al. 2008).
Nevertheless, the ﬁnding that adolescent THC-treated rats demonstrated strongly decreased social interaction behavior is
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Figure 7. Long-term effects of chronic THC exposure during adulthood on PFC synaptic markers. (A) Representative western blot for phosphorylated and total Akt
expression in the PFC (left). Densitometry analysis revealed no signiﬁcant changes in phosphorylated Akt-Thr308, the total Akt, and the ratio of phosphorylated to
total Akt in adult VEH- versus adult THC pretreated rats. (B) Representative western blot for phosphorylated and total Akt expression in the PFC (left). Densitometry
analysis revealed an increase in both phosphorylated Akt-Ser473 and the ratio of phosphorylated to total Akt in adult THC compared with adult VEH pretreated rats.
(C) Representative western blot for β-catenin expression in the PFC (left). No signiﬁcant changes were found in β-catenin expression in adult VEH- versus adult THC
pretreated rats. (D) Representative western blot for phosphorylated and total GSK-3α and β expression in the PFC (left). Densitometry analysis revealed an increase in
both phosphorylated GSK-3α and β isoforms and both the ratio of phosphorylated to total (GSK-3α and GSK-3β) in adult THC compared with adult VEH pretreated rats.
No signiﬁcant changes in total GSK-3α and β were found between groups. (E) Representative western blot for phosphorylated and total mTOR expression in the PFC (left).
Densitometry analysis revealed an increase in both phosphorylated mTOR and the ratio of phosphorylated to total mTOR in adult THC compared with VEH pretreated rats.
No signiﬁcant changes in total mTOR are observed. (F) Representative western blot for phosphorylated and total p70S6K expression in the PFC (left). Densitometry analysis
revealed no signiﬁcant changes in phosphorylated p70S6K, the ratio of phosphorylated to total p70S6K, and total p70S6K in adult THC compared with adult VEH pretreated
rats. n = 4–6 rats, t-tests; ** indicated P < 0.01; * indicated P < 0.05. Error bars represent the standard error of the means (SEMs).

indicative of disturbances in intrinsic motivational drive for social
interaction, a phenomenon commonly reported in schizophrenia
(Green and Horan 2010; Lee et al. 2013). Together, these ﬁndings
demonstrate that chronic THC exposure speciﬁcally during adolescence leads to deﬁcits in social motivation, consistent with clinical studies showing that heavy adolescent cannabis use is
associated with a persistent “amotivational syndrome” principally
deﬁned by lethargy, inactivity, and social withdrawal (Looby and
Earleywine 2007). In addition, consistent with the present ﬁndings,
recognition memory in rodents is deﬁned as the ability to discriminate the familiarity of recently encountered stimuli and is a functional index of working memory (Mumby 2001; Schneider et al.
2008). Importantly, working memory dysfunction is a core feature
of schizophrenia and other neuropsychiatric disorders (Bowie and
Harvey 2006), further suggesting that adolescent THC exposure
may induce neuropsychiatric-like cognitive deﬁcits.
We also observed signiﬁcant increases in trait anxiety levels
following adolescent THC exposure, consistent with other preclinical and clinical studies (Renard et al. 2014). Anxiety-related
symptoms are a common co-morbidity in schizophrenia and
other neuropsychiatric conditions (Achim et al. 2011). Interestingly,

we observed several baseline differences in measures of anxiety
and social interaction behaviors when testing occurred at early versus later stages of adulthood. Several possible reasons may account
for these differences. One possibility is the fact that younger versus
older rats have been shown previously to demonstrate different
baseline levels of anxiety in similar behavioral assays, with older
rats showing relatively lower levels (Slawecki 2005; Lynn and
Brown 2010). Furthermore, our ﬁndings with social interaction behaviors are similar to a previous report (Quinn et al. 2008) wherein
it was found that adult vehicle control groups demonstrated lower
levels of baseline social interaction relative to adolescent treated
groups. Thus, the present results are consistent with previous
studies showing both anxiety and social interaction/cognition abnormalities speciﬁcally following adolescent THC exposure and
tested at early adulthood (O’Shea et al. 2004; Quinn et al. 2008;
Schneider et al. 2008; Stopponi et al. 2014). However, it is important
to note that baseline differences between early versus later stages
of rat adulthood may have an inﬂuence on behavioral outcomes.
Sensorimotor gating deﬁcits represent another core cognitive
feature of schizophrenia (Braff and Geyer 1990). Using a standard
prepulse inhibition (PPI) test, we observed selective PPI deﬁcits
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following adolescent, but not adult THC exposure. PPI is commonly used to assess the ability to ﬁlter extraneous information
from relevant salient environmental sensory information. Disruptions of this ﬁltering mechanism have been postulated to
underlie sensory overstimulation, psychosis, and attentional
deﬁcits (Braff and Geyer 1990). Indeed, PPI impairments are
widely accepted as an endophenotype of schizophrenia with
high translational validity (Braff et al. 2001). Functionally, PPI is
thought to be regulated by cortico-limbic-striatopallidal circuitry in which DA transmission plays a central role (Koch 1999;
Swerdlow et al. 2001). Disruptions in PFC DAergic transmission
have been reported to induce disturbances in normal sensory ﬁltering (Koch and Bubser 1994). Furthermore, drugs that stimulate
DA release such as amphetamine (AMPH) cause profound disruptions in PPI (Geyer et al. 2001). Thus, the presently observed deficits in PPI are consistent with the hyper-DAergic phenotype
observed in adolescent THC-treated rats and point to a potential
mechanism that may account for deﬁcits in cognitive ﬁltering following selective adolescent THC exposure.
Prominent theories of schizophrenia suggest that dysregulated DAergic transmission and PFC dysfunction represent important underlying neuropathological features of schizophrenia
(Perlstein et al. 2001; Laviolette 2007). We report for the ﬁrst
time that THC exposure speciﬁcally during adolescence induces
a state of hyper-DAergic function in the mesocorticolimbic system, persisting into early adulthood. Cortical regulation of
sub-cortical DA neuronal activity states is indicated both by anatomical and by functional evidence. For example, a recent report
demonstrated persistent downregulation of the GABAergic
marker GAD 67 in the PFC of adult rats chronically exposed to
THC during adolescence (Zamberletti et al. 2014). Furthermore,
the PFC sends functional, excitatory descending projections to
VTA neuronal populations (French et al. 1997; Gessa et al. 1998)
which form excitatory synapses onto both DA and non-DA VTA
neurons. Thus, cortical disinhibition induced by THC exposure
may be sufﬁcient to induce cortical overdrive onto VTA DA neurons, leading to a hyper-DAergic phenotype. Indeed, we have recently reported that acute CB1R activation within the PFC is
capable of strongly activating VTA DA neurons and distorting
emotional salience processing through functional interactions
with recurrent, VTA→PFC DA receptor transmission (Draycott
et al. 2014). Furthermore, hyper-DAergic states underlying
schizophrenia have been associated with increased DAergic activity in both striatal and PFC regions (Lindström et al. 1999).
For example, hyper-DAergic activity within the PFC is associated
with schizophrenia-like cognitive disorganization (Murphy et al.
1996), and cognitive deﬁcits associated with schizophrenia have
been linked to dysregulations in PFC neuronal function (Perlstein
et al. 2001). Finally, we have reported that overstimulation of PFC
DA receptors can distort emotional memory processing and potentiate normally non-salient fear stimuli (Lauzon et al. 2013).
Interestingly, we observed decreased exploratory locomotor behavior in adolescent THC versus VEH-treated experimental
groups. While such a phenotype may seem counterintuitive to
the hyper-DAergic state observed in the adolescent treatment
group, 1 possibility is that these rats engaged in lower levels of exploratory locomotor activity as a consequence of increased levels
of anxiety, as demonstrated in our anxiety testing behavioral
assay.
The molecular underpinnings of schizophrenia-related psychopathology are complex and not entirely understood. Given
our ﬁndings demonstrating a state of sub-cortical hyper-DAergic
activity, we performed a series of molecular analyses within the
PFC to determine how VTA DAergic outputs may alter DA-related
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signaling pathways at the cortical level. Interestingly, we observed several molecular alterations in the PFC that may be
linked to a hyper-DAergic phenotype. Several signaling pathways
have emerged as important players in schizophrenia-related etiology. For example, the mTORC1 signaling pathway is recognized
as a critical integrator of synaptic plasticity, regulation of protein
synthesis, and cognitive processing (Hoeffer and Klann 2010).
Recent studies have also implicated the mTOR pathway in
neurodevelopmental and neuropsychiatric disorders, including
schizophrenia (Gururajan and Van Den Buuse 2014). GSK-3, the
major downstream target of Akt, is critical for the regulation of
transcription factors including β-catenin, which is an important
component of the Wnt signal transduction pathway (MacDonald
et al. 2009). GSK-3 also plays a central role in the regulation of the
mammalian target of rapamycin complex 1 (mTORC1) (Ma and
Blenis 2009), which includes mTOR and p70S6K.
Notably, we observed profound reductions in levels of phospho-GSK-3 α/β, mTOR, p70S6K, AKT (at threonine 308), and in
total β-Catenin levels, following adolescent THC exposure.
Thus, the persistent decrease in phosphorylated Akt-thr308 observed in the PFC of adolescent THC rats is mechanistically consistent with a decrease in levels of phosphorylated GSK3 and its
downstream signaling molecules (β-catenin and mTORC1). Importantly, consistent with our observed behavioral and neuronal
phenotypes, disturbances in these pathways have been linked
both to neuropsychiatric disorders and to dysregulation of DAergic function. For example, previous reports have demonstrated
signiﬁcant downregulation of GSK-3 α/β, AKT1, and β-catenin in
post-mortem PFC tissue samples from schizophrenia patients
(Beasley et al. 2001; Kozlovsky et al. 2001). In addition to schizophrenia, substantial reductions in levels of p70S6K and mTORC
have been observed in post-mortem PFC samples from mood disordered patients (Jernigan et al. 2011).
Interestingly, the dramatic reductions in PFC GSK-3α/β and
p70S6K phosphorylation levels that we observed following adolescent THC exposure are consistent with a hyper-DAergic
phenotype and DA receptor stimulation within the PFC. Indeed,
considerable evidence demonstrates that DA receptor transmission is capable of strongly modulating the phosphorylation states
of both AKT and GSK-3 pathways within the mammalian brain.
For example, pharmacological inhibition or genetic deletion of
the DA D2 receptor increases phosphorylated Akt-thr308 and
GSK3β in the striatum (Beaulieu 2011; Sutton and Rushlow
2012). In addition, transgenic mice lacking the DA transporter
(DAT–KO) demonstrate persistent mesolimbic hyper-dopaminergia and reduced Akt phosphorylation at threonine 308, concomitant with a reduction in the phosphorylation of GSK3α/β
(Beaulieu et al. 2004). A similar effect on Akt and GSK-3 has
been observed following the administration of psychostimulants
that increase extracellular DA concentrations, such as amphetamine (Polter et al. 2010). Furthermore, chronic administration
of DA D2 agonists, (which would be expected to mimic the presently observed hyper-DAergic state induced by THC), has been
shown to dramatically downregulate PFC levels of Akt and GSK3α/β (Sutton and Rushlow 2012). Finally, pharmacological stimulation of D2 receptors potently downregulates levels of p70S6K
(Fasano et al. 2008), consistent with the present ﬁndings. Thus,
the observed molecular PFC adaptations observed following adolescent (but not adulthood) THC exposure might be associated
with the known effects of a persistent hyper-DAergic state.
These results demonstrate for the ﬁrst time that adolescent
THC exposure may lead to schizophrenia-like DAergic alterations
in early adulthood which may in turn lead to a developmental
cascade of cognitive and affective abnormalities in early adulthood,
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consistent with schizophrenia-like symptomology. Although the
present study focused exclusively on the PFC, the effects of VTA
hyper-DAergic activity may be expected to impact molecular and
neuronal activity parameters in other VTA DAergic output targets, such as the nucleus accumbens (NAc) and/or basolateral
amygdala (BLA). Future studies are required to more fully investigate these possibilities.
Interestingly, in direct contrast to the effects of adolescent
exposure, adult THC exposure selectively increased levels of
phospho-GSK-3 α/β isoforms and Akt at serine 473 residue
(Akt-ser473), while having no effect on the expression levels of
other examined signaling pathways. Furthermore, since Aktser473 is a substrate of the mTOR Complex 2 (mTORC2) (Sarbassov et al. 2005), THC exposure during adulthood appears to have
a selective impact on the mTORC2 signaling pathway. Thus,
consistent with the dissociable effects of adolescent versus
adulthood THC exposure on other behavioral and DAergic neuronal activity, these ﬁndings demonstrate that THC exposure
during adolescence has a selective effect on modulating schizophrenia-related molecular, neuronal, and behavioral endophenotypes, which are not affected following adulthood exposure.
However, it is important to note that while the present preclinical study revealed several intriguing neuronal, molecular, and
behavioral phenomena in experimental animals consistent
with clinical and neuropathological features of schizophrenia,
these disturbances are observed also in other complex neuropsychiatric disorders, such as mood disturbances (Beaulieu
et al. 2004; Gould et al. 2004; Jernigan et al. 2011). Caution is
therefore warranted when applying these ﬁndings to potential
side effects associated with adolescent MJ exposure.
Interestingly, recent reports have linked alterations in the
mTORC2 pathway to neuronal plasticity and cytoskeletal regulation as opposed to mTORC1, which is closely linked to synaptic
plasticity mechanisms (Hoeffer and Klann 2010). In addition,
mTORC2 has been linked to DAergic neuroadaptations associated with chronic opiate exposure and decreased DA release
within the mesolimbic pathway (Mazei-Robison et al. 2011).
While we observed no changes in spontaneous DAergic neuronal
activity following adulthood THC exposure, 1 intriguing possibility is that the observed alterations selectively in the mTORC2
pathway may relate to an adaptive response to repeated THC-induced DAergic modulation that is present in the adult brain, but
absent during adolescent neurodevelopment. Future studies are
required to more fully characterize the potential phenotypic effects related to these observed molecular adaptations following
adulthood THC exposure.
In summary, consistent with a growing body of clinical evidence, the present ﬁndings demonstrate that adolescence represents a selective neurodevelopmental window of vulnerability
wherein the developing brain is particularly sensitive to the effects of chronic THC exposure. Given the exponential global rise
in cannabis use for both recreational and therapeutic purposes,
these ﬁndings have critical implications for public health policy
development related to regulating adolescent versus adulthood
exposure to cannabis.
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